UiPath Named Leader in Forrester's Adaptive Process Orchestration Wave, Bolstering Agentic Automation Positioning

What happened

UiPath announced on October 7, 2026, that it has been recognized as a Leader in The Forrester Wave: Adaptive Process Orchestration Software, Q3 2026. This third-party validation comes as the company repositions from traditional RPA to intelligent, agentic automation orchestration, a shift highlighted in the latest DeepValue report. The report rates PATH as a potential buy with a base case value of $12.50, contingent on ARR growth holding near 12% and net retention above 108%. The Forrester leadership designation may strengthen UiPath's credibility in enterprise evaluations, potentially supporting its ability to win larger deals and expand within existing accounts. However, the report cautions that the key near-term checkpoint remains Q2 FY27 ARR results, which must land within the guided $1.929B–$1.934B range to validate the thesis.

Implication

The Forrester Wave leadership position is a positive signal that UiPath's orchestration platform is gaining independent recognition, which may help counteract fears of displacement by bundled AI tools. This could translate into better win rates and pricing power, particularly in large enterprise deals where analyst reports influence vendor selection. However, the investment thesis remains tied to hard metrics: sustained net-new ARR above $40 million per quarter and NRR staying at 108% or higher. The report's scenario analysis puts a 50% probability on a $12.50 value, but that assumes continued enterprise standardization; if the Forrester recognition does not convert into bookings over the next two quarters, the bear case of $8 becomes more plausible. Investors should treat this news as a modest positive catalyst but wait for Q2 FY27 results before adjusting positions.

Thesis delta

The Forrester leader designation provides external validation of UiPath's adaptive process orchestration capabilities, marginally reinforcing the agentic automation narrative. However, the core thesis does not shift: the stock remains a prove-it story hinging on ARR growth durability and retention above 108%. No change is made to the potential buy rating or the $10 attractive entry, pending confirmation from upcoming quarterly results.